Anita Liberman

Person

Ramat Aviv, IL

People

Patents Grantslast 30 patents

Information Patent Grant
DNT-maleate and methods of preparation thereof
- Patent number 7,842,717
- Issue date Nov 30, 2010
- Teva Pharmaceutical Industries Ltd.
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of du...
- Patent number 7,759,500
- Issue date Jul 20, 2010
- Teva Pharmaceutical Industries Ltd.
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted ben...
- Patent number 7,683,177
- Issue date Mar 23, 2010
- Teva Pharmaceutical Industries Ltd.
- Viviana Braude
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable iansoprazole containing more than 500 ppm, up to about 3,000...
- Patent number 7,683,080
- Issue date Mar 23, 2010
- Teva Pharmaceutical Industries Ltd.
- Anita Liberman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of stabilizing lansoprazole
- Patent number 7,678,816
- Issue date Mar 16, 2010
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the purification of lansoprazole
- Patent number 7,622,588
- Issue date Nov 24, 2009
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the purification of duloxetine hydrochloride
- Patent number 7,534,900
- Issue date May 19, 2009
- Teva Pharmaceutical Industries Ltd.
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-th...
- Patent number 7,399,871
- Issue date Jul 15, 2008
- Teva Pharmaceutical Industries Ltd.
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline hydrochloride form II and methods for the preparation th...
- Patent number 7,319,171
- Issue date Jan 15, 2008
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline hydrochloride form II and methods for the preparation th...
- Patent number 7,196,222
- Issue date Mar 27, 2007
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the purification of lansoprazole
- Patent number 7,060,837
- Issue date Jun 13, 2006
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the purification of lansoprazole
- Patent number 7,022,859
- Issue date Apr 4, 2006
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline hydrochloride polymorphs
- Patent number 7,022,881
- Issue date Apr 4, 2006
- TEVA Pharmaceutical Industries, Ltd.
- Eduard Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the purification of lansoprazole
- Patent number 6,909,004
- Issue date Jun 21, 2005
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for synthesizing leflunomide
- Patent number 6,723,855
- Issue date Apr 20, 2004
- Teva Pharmaceutical Industries Ltd.
- Ilya Avrutov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparation of sertraline hydrochloride polymorphs
- Patent number 6,600,073
- Issue date Jul 29, 2003
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis and crystallization of piperazine ring-containing compounds
- Patent number 6,576,764
- Issue date Jun 10, 2003
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis and crystallization of piperazine ring-containing compounds
- Patent number 6,545,149
- Issue date Apr 8, 2003
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline hydrochloride polymorphs
- Patent number 6,500,987
- Issue date Dec 31, 2002
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sertraline hydrochloride Form II and methods for the preparation th...
- Patent number 6,495,721
- Issue date Dec 17, 2002
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALL...
- Publication number 20100029943
- Publication date Feb 4, 2010
- Teva Pharmaceutical Industries Ltd.
- Marioara MENDELOVICI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-Napathalenyloxy)-3-(2-th...
- Publication number 20090012316
- Publication date Jan 8, 2009
- Teva Pharmaceuticals USA, Inc.
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sertraline hydrochloride form II and methods for the preparation th...
- Publication number 20080287550
- Publication date Nov 20, 2008
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sertraline hydrochloride polymorphs
- Publication number 20080176949
- Publication date Jul 24, 2008
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYMORPHS OF ESZOPICLONE MALATE
- Publication number 20080027223
- Publication date Jan 31, 2008
- Teva Pharmaceutical Industries Ltd.
- Alex Mainfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted ben...
- Publication number 20080004319
- Publication date Jan 3, 2008
- Viviana Braude
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALLY...
- Publication number 20070270590
- Publication date Nov 22, 2007
- Marioara MENDELOVICI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of du...
- Publication number 20070191472
- Publication date Aug 16, 2007
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DNT-fumarate and methods of preparation thereof
- Publication number 20070191471
- Publication date Aug 16, 2007
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNT-maleate and methods of preparation thereof
- Publication number 20070185192
- Publication date Aug 9, 2007
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sertraline hydrochloride form II and methods for the preparation th...
- Publication number 20070093557
- Publication date Apr 26, 2007
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sertraline hydrochloride form II and methods for the preparation th...
- Publication number 20070038005
- Publication date Feb 15, 2007
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the purification of duloxetine hydrochloride
- Publication number 20060276660
- Publication date Dec 7, 2006
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystal forms of (S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-th...
- Publication number 20060270860
- Publication date Nov 30, 2006
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pure duloxetine hydrochloride
- Publication number 20060270731
- Publication date Nov 30, 2006
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for the preparation of optically active (S)-(+)-N,N-dimethy...
- Publication number 20060270861
- Publication date Nov 30, 2006
- Santiago Ini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sertraline hydrochloride polymorphs
- Publication number 20060241189
- Publication date Oct 26, 2006
- Teva Pharmaceutical Industries Ltd.
- Eduard Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for preparing pharmaceutically acceptable salts of duloxeti...
- Publication number 20060194869
- Publication date Aug 31, 2006
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purification of tegaserod maleate
- Publication number 20060128788
- Publication date Jun 15, 2006
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Preparation of tegaserod and tegaserod maleate
- Publication number 20060106086
- Publication date May 18, 2006
- Santiago Ini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for the purification of lansoprazole
- Publication number 20050165061
- Publication date Jul 28, 2005
- Teva Pharmaceuticals Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for the purification of lansoprazole
- Publication number 20050165059
- Publication date Jul 28, 2005
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for the purification of lansoprazole
- Publication number 20050165060
- Publication date Jul 28, 2005
- Teva Pharmaceutical Industries Ltd.
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted ben...
- Publication number 20050075370
- Publication date Apr 7, 2005
- Viviana Braude
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of stabilizing lansoprazole
- Publication number 20050020638
- Publication date Jan 27, 2005
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sertraline hydrochloride form II and methods for the preparation th...
- Publication number 20040220279
- Publication date Nov 4, 2004
- Eduard Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sertraline hydrochloride polymorphs
- Publication number 20040220280
- Publication date Nov 4, 2004
- Eduard Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stable lansoprazole containing more than 500 ppm, up to about 3,000...
- Publication number 20040215021
- Publication date Oct 28, 2004
- Anita Liberman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for the purification of lansoprazole
- Publication number 20040192923
- Publication date Sep 30, 2004
- Claude Singer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel synthesis and crystallization of peperazine ring-containing c...
- Publication number 20040176591
- Publication date Sep 9, 2004
- Claude Singer
- C07 - ORGANIC CHEMISTRY

Anita Liberman

Person

Patents Grantslast 30 patents

DNT-maleate and methods of preparation thereof

2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of du...

Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted ben...

Stable iansoprazole containing more than 500 ppm, up to about 3,000...

Method of stabilizing lansoprazole

Method for the purification of lansoprazole

Process for the purification of duloxetine hydrochloride

Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-th...

Sertraline hydrochloride form II and methods for the preparation th...

Sertraline hydrochloride form II and methods for the preparation th...

Method for the purification of lansoprazole

Method for the purification of lansoprazole

Sertraline hydrochloride polymorphs

Method for the purification of lansoprazole

Method for synthesizing leflunomide

Methods for preparation of sertraline hydrochloride polymorphs

Synthesis and crystallization of piperazine ring-containing compounds

Synthesis and crystallization of piperazine ring-containing compounds

Sertraline hydrochloride polymorphs

Sertraline hydrochloride Form II and methods for the preparation th...

Patents Applicationslast 30 patents

METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALL...

Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-Napathalenyloxy)-3-(2-th...

Sertraline hydrochloride form II and methods for the preparation th...

Sertraline hydrochloride polymorphs

POLYMORPHS OF ESZOPICLONE MALATE

Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted ben...

METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALLY...

2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of du...

DNT-fumarate and methods of preparation thereof

DNT-maleate and methods of preparation thereof

Sertraline hydrochloride form II and methods for the preparation th...

Sertraline hydrochloride form II and methods for the preparation th...

Process for the purification of duloxetine hydrochloride

Crystal forms of (S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-th...

Pure duloxetine hydrochloride

Process for the preparation of optically active (S)-(+)-N,N-dimethy...

Sertraline hydrochloride polymorphs

Process for preparing pharmaceutically acceptable salts of duloxeti...

Purification of tegaserod maleate

Preparation of tegaserod and tegaserod maleate

Method for the purification of lansoprazole

Method for the purification of lansoprazole

Method for the purification of lansoprazole

Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted ben...

Method of stabilizing lansoprazole

Sertraline hydrochloride form II and methods for the preparation th...

Sertraline hydrochloride polymorphs

Stable lansoprazole containing more than 500 ppm, up to about 3,000...

Method for the purification of lansoprazole

Novel synthesis and crystallization of peperazine ring-containing c...